Latest Insider Transactions at Apollo Medical Holdings, Inc. (AMEH)
This section provides a real-time view of insider transactions for Apollo Medical Holdings, Inc. (AMEH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Apollo Medical Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Apollo Medical Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,831
-3.03%
|
$170,775
$25.06 P/Share
|
|
Jun 11
2025
|
Linda Marsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+7.16%
|
-
|
|
Jun 11
2025
|
Matthew Mazdyasni Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+30.4%
|
-
|
|
Jun 11
2025
|
David Schmidt Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+29.03%
|
-
|
|
Jun 11
2025
|
John Chiang Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+21.8%
|
-
|
|
Jun 11
2025
|
Dai, Weili Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+32.07%
|
-
|
|
Jun 11
2025
|
Mitchell W Kitayama Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+23.44%
|
-
|
|
Jun 04
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,656
-0.73%
|
$41,400
$25.06 P/Share
|
|
May 16
2025
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,035
-5.32%
|
$270,945
$27.18 P/Share
|
|
Apr 29
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
828
-0.36%
|
$25,668
$31.15 P/Share
|
|
Apr 14
2025
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,683
-1.4%
|
$91,222
$34.05 P/Share
|
|
Apr 02
2025
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,394
-0.72%
|
$41,820
$30.02 P/Share
|
|
Mar 26
2025
|
Glenn Sobotka Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,701
+43.0%
|
-
|
|
Mar 05
2025
|
Brandon Sim CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
105,795
-9.37%
|
$2,856,465
$27.19 P/Share
|
|
Mar 05
2025
|
Brandon Sim CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
145,642
+11.43%
|
-
|
|
Mar 05
2025
|
Chandan Basho COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
26,701
+12.17%
|
-
|
|
Mar 05
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,866
-3.33%
|
$212,382
$27.19 P/Share
|
|
Mar 05
2025
|
Dinesh M. Kumar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,701
+10.16%
|
-
|
|
Mar 05
2025
|
Thomas S. Lam Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,235
-2.1%
|
$249,345
$27.19 P/Share
|
|
Feb 15
2025
|
Thomas S. Lam Director |
BUY
Other acquisition or disposition
|
Indirect |
26,232
+2.26%
|
-
|
|
Feb 15
2025
|
Thomas S. Lam Director |
SELL
Other acquisition or disposition
|
Indirect |
699,896
-10.24%
|
-
|
|
Feb 15
2025
|
Allied Physicians Of California, A Profession Medical Corp > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
699,896
-10.24%
|
-
|
|
Feb 15
2025
|
Kenneth T. Sim Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
26,232
+4.58%
|
-
|
|
Feb 15
2025
|
Kenneth T. Sim Executive Chairman |
SELL
Other acquisition or disposition
|
Indirect |
699,896
-10.24%
|
-
|
|
Jan 23
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,210
-3.33%
|
$266,770
$37.96 P/Share
|
|
Jan 17
2025
|
Allied Physicians Of California, A Profession Medical Corp > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
300,000
-4.21%
|
$10,500,000
$35.17 P/Share
|
|
Jan 01
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
967
-0.45%
|
$29,977
$31.53 P/Share
|
|
Dec 10
2024
|
Mitchell W Kitayama Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,100
-25.87%
|
$219,300
$43.09 P/Share
|
|
Nov 30
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.76%
|
$5,762
$43.25 P/Share
|
|
Nov 22
2024
|
Mitchell W Kitayama Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,490
-7.03%
|
$62,580
$42.11 P/Share
|
|
Nov 22
2024
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,409
+13.85%
|
$61,362
$18.41 P/Share
|
|
Nov 19
2024
|
John Chiang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-3.92%
|
$27,240
$40.93 P/Share
|
|
Nov 19
2024
|
John Chiang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,515
+8.02%
|
$27,270
$18.41 P/Share
|
|
Nov 18
2024
|
Kenneth T. Sim Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
28,046
+4.4%
|
$504,828
$18.65 P/Share
|
|
Nov 12
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
636
-3.48%
|
$26,712
$42.91 P/Share
|
|
Nov 08
2024
|
Dinesh M. Kumar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,238
+23.67%
|
-
|
|
Nov 08
2024
|
Kenneth T. Sim Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+15.79%
|
-
|
|
Nov 08
2024
|
Thomas S. Lam Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+4.43%
|
-
|
|
Nov 08
2024
|
Brandon Sim CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
34,386
+3.38%
|
-
|
|
Nov 08
2024
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
691
-0.41%
|
$31,786
$46.96 P/Share
|
|
Nov 08
2024
|
Chandan Basho COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,510
+8.51%
|
-
|
|
Oct 02
2024
|
Brandon Sim CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,626
-0.28%
|
$149,682
$57.87 P/Share
|
|
Sep 10
2024
|
Linda Marsh Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,522
-4.36%
|
$165,534
$47.93 P/Share
|
|
Sep 10
2024
|
Linda Marsh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+11.99%
|
$165,000
$15.35 P/Share
|
|
Sep 10
2024
|
Mitchell W Kitayama Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,522
-16.52%
|
$165,534
$47.93 P/Share
|
|
Sep 10
2024
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+34.04%
|
$165,000
$15.35 P/Share
|
|
Sep 09
2024
|
John Chiang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,565
-18.36%
|
$167,555
$47.35 P/Share
|
|
Sep 09
2024
|
John Chiang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+36.17%
|
$165,000
$15.35 P/Share
|
|
Sep 09
2024
|
Thomas S. Lam Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,046
-2.69%
|
$519,162
$47.35 P/Share
|
|
Sep 09
2024
|
Thomas S. Lam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,046
+6.4%
|
$504,828
$18.65 P/Share
|